image
RedHill Biopharma Ltd. RDHL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
Watchlist
$ 7.29
6.11 %
$ 9.29 M
Market Cap
-0.02
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -89.46% 140.37% 129.48%
Annual Report FY 10-K 2022-12-31 -27.94% 48.17% 47.19%
Annual Report FY 10-K 2021-12-31 33.25% -28.41% -27.40%
Annual Report FY 10-K 2020-12-31 923.03% -104.01% -47.41%
Annual Report FY 10-K 2019-12-31 -24.75% -12.40% -9.84%
Annual Report FY 10-K 2018-12-31 108.63% 14.76% 24.32%
Annual Report FY 10-K 2017-12-31 3867.33% -55.07% -70.16%
Annual Report FY 10-K 2016-12-31 3266.67% -39.26% -38.82%
Annual Report FY 10-K 2015-12-31 -99.96% -96.90% -106.65%
Annual Report FY 10-K 2014-12-31 58350.00% -0.78% 1.16%
Annual Report FY 10-K 2013-12-31 -25.00% -2.92% -19.16%
Annual Report FY 10-K 2012-12-31 -30.43% 33.39% -14.82%
Annual Report FY 10-K 2011-12-31 0.00% -509.39% -354.30%
Annual Report FY 10-K 2010-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2023-06-30 -90.21% 105.34% 51.87%
Quarterly Report Q1 8-K 2023-03-31 -80.26% 393.17% 482.70%
Quarterly Report Q4 8-K 2022-12-31 -42.01% 110.22% 51.94%
Quarterly Report Q3 8-K 2022-09-30 -18.77% -200.62% 59.14%
Quarterly Report Q2 8-K 2022-06-30 -14.68% 51.02% 63.20%
Quarterly Report Q1 8-K 2022-03-31 -11.37% 25.04% 27.07%
Quarterly Report Q4 8-K 2021-12-31 2.84% -0.17% -5.03%
Quarterly Report Q3 8-K 2021-09-30 3.18% -14.75% -20.32%
Quarterly Report Q2 8-K 2021-06-30 2.89% -81.47% -99.09%
Quarterly Report Q1 8-K 2021-03-31 1848.39% -33.26% -6.68%
Quarterly Report Q4 8-K 2020-12-31 1249.75% -108.12% -67.53%
Quarterly Report Q3 8-K 2020-09-30 1394.86% -89.51% -46.89%
Quarterly Report Q2 8-K 2020-06-30 1237.11% -47.11% -0.97%
Quarterly Report Q1 8-K 2020-03-31 -39.21% -73.83% -84.70%
Quarterly Report Q4 8-K 2019-12-31 17.00% -52.15% -17.14%
Quarterly Report Q3 8-K 2019-09-30 -36.49% 2.46% -1.11%
Quarterly Report Q2 8-K 2019-06-30 -33.49% 1.89% -29.54%
Quarterly Report Q1 8-K 2019-03-31 -28.96% 0.65% 7.82%
Quarterly Report Q4 8-K 2018-12-31 -32.08% 26.21% 30.09%
Quarterly Report Q3 8-K 2018-09-30 44.85% 35.00% 30.28%
Quarterly Report Q2 8-K 2018-06-30 386.54% -0.86% 29.41%
Quarterly Report Q1 8-K 2018-03-31 0.00% -15.58% 1.06%
Quarterly Report Q4 8-K 2017-12-31 1901.00% -24.72% -59.76%
Quarterly Report Q3 8-K 2017-09-30 0.00% -73.43% -65.19%
Quarterly Report Q2 8-K 2017-06-30 48200.00% -68.24% -88.20%
Quarterly Report Q1 8-K 2017-03-31 0.00% -55.61% -71.13%
Quarterly Report Q4 8-K 2016-12-31 0.00% -27.27% -32.92%
Quarterly Report Q3 8-K 2016-09-30 0.00% -171.69% -84.10%
Quarterly Report Q2 8-K 2016-06-30 0.00% 0.67% -22.14%
Quarterly Report Q1 8-K 2016-03-31 0.00% -19.00% -24.14%
Quarterly Report Q4 8-K 2015-12-31 0.00% -23.12% -40.53%
Quarterly Report Q3 8-K 2015-09-30 -75.00% 22.29% 8.36%
Quarterly Report Q2 8-K 2015-06-30 -75.00% -45.80% -43.17%
Quarterly Report Q1 8-K 2015-03-31 -99.99% -137.46% -144.44%
Quarterly Report Q4 8-K 2014-12-31 0.00% -54.88% -38.33%
Quarterly Report Q3 8-K 2014-09-30 33.33% -56.95% -82.28%
Quarterly Report Q2 8-K 2014-06-30 0.00% -80.10% -62.87%
Quarterly Report Q1 8-K 2014-03-31 175025.00% 270.81% 263.21%
Quarterly Report Q4 8-K 2013-12-31 -75.00% -2.63% -64.54%
Quarterly Report Q3 8-K 2013-09-30 0.00% -37.21% -42.73%
Quarterly Report Q2 8-K 2013-06-30 -20.00% -10.51% -22.27%
Quarterly Report Q1 8-K 2013-03-31 0.00% 27.69% 31.23%
Quarterly Report Q4 8-K 2012-12-31 33.33% -27.94% 13.99%
Quarterly Report Q3 8-K 2012-09-30 -72.73% 27.92% 13.09%
Quarterly Report Q2 8-K 2012-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2012-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2011-09-30 0.00% 0.00% 0.00%